Imogaze (Simeticone)

Simethicone reduces the surface tension of gas bubbles within the stomach and intestines. This causes small bubbles to merge into larger ones that can be passed more readily through belching or flatulence, thereby decreasing the sensation of pressure and distension.

The appropriate dose of Imogaze is determined by the prescribing healthcare professional based on the patient’s age, condition and response. Patients should follow the prescriber’s instructions and the product label for correct use.

Safety data for simethicone in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Imogaze with their healthcare provider before starting treatment.

To order Imogaze, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Imogaze’s active ingredient, simethicone, is the same antifoaming agent found in many over‑the‑counter gas‑relief products. Its efficacy is comparable, but formulation differences such as tablet, chewable or liquid forms may affect patient preference and ease of administration.

Imogaze should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Imogaze is taken orally. The tablet or liquid is swallowed with water as directed by the prescriber, usually after meals or as needed for symptom relief. Do not crush or chew tablets unless the product label specifically permits it.

Serious but rare risks include allergic reactions such as rash, itching, swelling of the face, lips or throat, and severe abdominal pain. If any of these occur, discontinue use and seek immediate medical attention.

Individuals with a known hypersensitivity to simethicone or any excipients in the formulation should avoid Imogaze. Additionally, it should be used with caution in infants, young children, pregnant or breastfeeding women unless advised by a healthcare professional.